AnaptysBio, Inc. (ANAB) Misses Q1 EPS by 88c
Tweet
Share
E-mail
Get Alerts ANAB Hot Sheet
Join SI Premium – FREE
AnaptysBio, Inc. (NASDAQ: ANAB) reported Q1 EPS of ($1.84), $0.88 worse than the analyst estimate of ($0.96). Revenue for the quarter came in at $25.56 million versus the consensus estimate of $23.04 million.
For earnings history and earnings-related data on AnaptysBio, Inc. (ANAB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Cerebras Systems posts 94% revenue jump, announces OpenAI deal
- After-Hours Stock Movers: FDX, CBRS, NKE
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
